Showing results (1-10 of 58) with videos related to

Sort By:
Pageof 6
Hospital Practice (1995)|March 8, 2013
Inhibitory effect of apixaban compared with rivaroxaban and dabigatran on thrombin generation assayPancras C Wong, Andrew White, Joseph Luettgen
Journal of Thrombosis and Thrombolysis|December 15, 2015
The P2Y1 receptor antagonist MRS2500 prevents carotid artery thrombosis in cynomolgus monkeysPancras C Wong, Carol Watson, Earl J Crain
Journal of Thrombosis and Thrombolysis|February 15, 2011
Preclinical discovery of apixaban, a direct and orally bioavailable factor Xa inhibitorPancras C Wong, Donald J P Pinto, Donglu Zhang
Cardiovascular Drug Reviews|August 15, 2002
Nonpeptide factor Xa inhibitors: DPC423, a highly potent and orally bioavailable pyrazole antithrombotic agentPancras C Wong, Donald J P Pinto, Robert M Knabb
Journal of Thrombosis and Thrombolysis|May 27, 2011
A small-molecule factor XIa inhibitor produces antithrombotic efficacy with minimal bleeding time prolongation in rabbitsPancras C Wong, Earl J Crain, Carol A Watson, et al.
Thrombosis and Haemostasis|January 10, 2009
Clopidogrel versus prasugrel in rabbits. Effects on thrombosis, haemostasis, platelet function and response variabilityPancras C Wong, Earl J Crain, Carol A Watson, et al.
Journal of Cardiovascular Pharmacology|March 13, 2010
Effect of the direct factor Xa inhibitor apixaban in rat models of thrombosis and hemostasisWilliam A Schumacher, Jeffrey S Bostwick, Anne B Stewart, et al.
Pageof 6